Global (United States, European Union and China) Cardiopulmonary Autotransfusion Devices Market Research Report 2019-2025
Table of Contents
1 Report Overview
- 1.1 Research Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Cardiopulmonary Autotransfusion Devices Market Size Growth Rate by Type (2019-2025)
- 1.3.2 On-Pump Transfusion Device
- 1.3.3 Off-Pump Transfusion Device
- 1.4 Market Segment by Application
- 1.4.1 Global Cardiopulmonary Autotransfusion Devices Market Share by Application (2019-2025)
- 1.4.2 Hospitals
- 1.4.3 Ambulatory Surgical Center
- 1.4.4 Cardiac Research Centers
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Production and Capacity Analysis
- 2.1.1 Global Cardiopulmonary Autotransfusion Devices Production Value 2014-2025
- 2.1.2 Global Cardiopulmonary Autotransfusion Devices Production 2014-2025
- 2.1.3 Global Cardiopulmonary Autotransfusion Devices Capacity 2014-2025
- 2.1.4 Global Cardiopulmonary Autotransfusion Devices Marketing Pricing and Trends
- 2.2 Key Producers Growth Rate (CAGR) 2019-2025
- 2.2.1 Global Cardiopulmonary Autotransfusion Devices Market Size CAGR of Key Regions
- 2.2.2 Global Cardiopulmonary Autotransfusion Devices Market Share of Key Regions
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Capacity and Production by Manufacturers
- 3.1.1 Global Cardiopulmonary Autotransfusion Devices Capacity by Manufacturers
- 3.1.2 Global Cardiopulmonary Autotransfusion Devices Production by Manufacturers
- 3.2 Revenue by Manufacturers
- 3.2.1 Cardiopulmonary Autotransfusion Devices Revenue by Manufacturers (2014-2019)
- 3.2.2 Cardiopulmonary Autotransfusion Devices Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Cardiopulmonary Autotransfusion Devices Market Concentration Ratio (CR5 and HHI)
- 3.3 Cardiopulmonary Autotransfusion Devices Price by Manufacturers
- 3.4 Key Manufacturers Cardiopulmonary Autotransfusion Devices Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Cardiopulmonary Autotransfusion Devices Market
- 3.6 Key Manufacturers Cardiopulmonary Autotransfusion Devices Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Production and Production Value for Each Type
- 4.1.1 On-Pump Transfusion Device Production and Production Value (2014-2019)
- 4.1.2 Off-Pump Transfusion Device Production and Production Value (2014-2019)
- 4.2 Global Cardiopulmonary Autotransfusion Devices Production Market Share by Type
- 4.3 Global Cardiopulmonary Autotransfusion Devices Production Value Market Share by Type
- 4.4 Cardiopulmonary Autotransfusion Devices Ex-factory Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Cardiopulmonary Autotransfusion Devices Consumption by Application
6 Production by Regions
- 6.1 Global Cardiopulmonary Autotransfusion Devices Production (History Data) by Regions 2014-2019
- 6.2 Global Cardiopulmonary Autotransfusion Devices Production Value (History Data) by Regions
- 6.3 United States
- 6.3.1 United States Cardiopulmonary Autotransfusion Devices Production Growth Rate 2014-2019
- 6.3.2 United States Cardiopulmonary Autotransfusion Devices Production Value Growth Rate 2014-2019
- 6.3.3 Key Players in United States
- 6.3.4 United States Cardiopulmonary Autotransfusion Devices Import & Export
- 6.4 European Union
- 6.4.1 European Union Cardiopulmonary Autotransfusion Devices Production Growth Rate 2014-2019
- 6.4.2 European Union Cardiopulmonary Autotransfusion Devices Production Value Growth Rate 2014-2019
- 6.4.3 Key Players in European Union
- 6.4.4 European Union Cardiopulmonary Autotransfusion Devices Import & Export
- 6.5 China
- 6.5.1 China Cardiopulmonary Autotransfusion Devices Production Growth Rate 2014-2019
- 6.5.2 China Cardiopulmonary Autotransfusion Devices Production Value Growth Rate 2014-2019
- 6.5.3 Key Players in China
- 6.5.4 China Cardiopulmonary Autotransfusion Devices Import & Export
- 6.6 Rest of World
- 6.6.1 Japan
- 6.6.2 Korea
- 6.6.3 India
- 6.6.4 Southeast Asia
7 Cardiopulmonary Autotransfusion Devices Consumption by Regions
- 7.1 Global Cardiopulmonary Autotransfusion Devices Consumption (History Data) by Regions
- 7.2 United States
- 7.2.1 United States Cardiopulmonary Autotransfusion Devices Consumption by Type
- 7.2.2 United States Cardiopulmonary Autotransfusion Devices Consumption by Application
- 7.3 European Union
- 7.3.1 European Union Cardiopulmonary Autotransfusion Devices Consumption by Type
- 7.3.2 European Union Cardiopulmonary Autotransfusion Devices Consumption by Application
- 7.4 China
- 7.4.1 China Cardiopulmonary Autotransfusion Devices Consumption by Type
- 7.4.2 China Cardiopulmonary Autotransfusion Devices Consumption by Application
- 7.5 Rest of World
- 7.5.1 Rest of World Cardiopulmonary Autotransfusion Devices Consumption by Type
- 7.5.2 Rest of World Cardiopulmonary Autotransfusion Devices Consumption by Application
- 7.5.1 Japan
- 7.5.2 Korea
- 7.5.3 India
- 7.5.4 Southeast Asia
8 Company Profiles
- 8.1 Fresenius Kabi
- 8.1.1 Fresenius Kabi Company Details
- 8.1.2 Company Description and Business Overview
- 8.1.3 Production and Revenue of Cardiopulmonary Autotransfusion Devices
- 8.1.4 Cardiopulmonary Autotransfusion Devices Product Introduction
- 8.1.5 Fresenius Kabi Recent Development
- 8.2 Haemonetics
- 8.2.1 Haemonetics Company Details
- 8.2.2 Company Description and Business Overview
- 8.2.3 Production and Revenue of Cardiopulmonary Autotransfusion Devices
- 8.2.4 Cardiopulmonary Autotransfusion Devices Product Introduction
- 8.2.5 Haemonetics Recent Development
- 8.3 LivaNova
- 8.3.1 LivaNova Company Details
- 8.3.2 Company Description and Business Overview
- 8.3.3 Production and Revenue of Cardiopulmonary Autotransfusion Devices
- 8.3.4 Cardiopulmonary Autotransfusion Devices Product Introduction
- 8.3.5 LivaNova Recent Development
- 8.4 Medtronic
- 8.4.1 Medtronic Company Details
- 8.4.2 Company Description and Business Overview
- 8.4.3 Production and Revenue of Cardiopulmonary Autotransfusion Devices
- 8.4.4 Cardiopulmonary Autotransfusion Devices Product Introduction
- 8.4.5 Medtronic Recent Development
- 8.5 Terumo
- 8.5.1 Terumo Company Details
- 8.5.2 Company Description and Business Overview
- 8.5.3 Production and Revenue of Cardiopulmonary Autotransfusion Devices
- 8.5.4 Cardiopulmonary Autotransfusion Devices Product Introduction
- 8.5.5 Terumo Recent Development
- 8.6 Stryker
- 8.6.1 Stryker Company Details
- 8.6.2 Company Description and Business Overview
- 8.6.3 Production and Revenue of Cardiopulmonary Autotransfusion Devices
- 8.6.4 Cardiopulmonary Autotransfusion Devices Product Introduction
- 8.6.5 Stryker Recent Development
- 8.7 Atrium Medical
- 8.7.1 Atrium Medical Company Details
- 8.7.2 Company Description and Business Overview
- 8.7.3 Production and Revenue of Cardiopulmonary Autotransfusion Devices
- 8.7.4 Cardiopulmonary Autotransfusion Devices Product Introduction
- 8.7.5 Atrium Medical Recent Development
9 Market Forecast
- 9.1 Global Market Size Forecast
- 9.1.1 Global Cardiopulmonary Autotransfusion Devices Capacity, Production Forecast 2019-2025
- 9.1.2 Global Cardiopulmonary Autotransfusion Devices Production Value Forecast 2019-2025
- 9.2 Market Forecast by Regions
- 9.2.1 Global Cardiopulmonary Autotransfusion Devices Production and Value Forecast by Regions 2019-2025
- 9.2.2 Global Cardiopulmonary Autotransfusion Devices Consumption Forecast by Regions 2019-2025
- 9.3 United States
- 9.3.1 Production and Value Forecast in United States
- 9.3.2 Consumption Forecast in United States
- 9.4 European Union
- 9.4.1 Production and Value Forecast in European Union
- 9.4.2 Consumption Forecast in European Union
- 9.5 China
- 9.5.1 Production and Value Forecast in China
- 9.5.2 Consumption Forecast in China
- 9.6 Rest of World
- 9.6.1 Japan
- 9.6.2 Korea
- 9.6.3 India
- 9.6.4 Southeast Asia
- 9.7 Forecast by Type
- 9.7.1 Global Cardiopulmonary Autotransfusion Devices Production Forecast by Type
- 9.7.2 Global Cardiopulmonary Autotransfusion Devices Production Value Forecast by Type
- 9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
- 10.1 Value Chain Analysis
- 10.2 Sales Channels Analysis
- 10.2.1 Cardiopulmonary Autotransfusion Devices Sales Channels
- 10.2.2 Cardiopulmonary Autotransfusion Devices Distributors
- 10.3 Cardiopulmonary Autotransfusion Devices Customers
11 Opportunities & Challenges, Threat and Affecting Factors
- 11.1 Market Opportunities
- 11.2 Market Challenges
- 11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
- 13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
- 13.1.1 Methodology/Research Approach
- 13.2 Author Details
Autotransfusion is also known as intraoperative blood salvage. It is a process in which blood is collected from active bleeding site of patient and rein fused into the same patient during cardiac surgery. Several commercial autotransfusion devices are available in market. There are three types of autotransfusion system namely; continuous flow centrifugal system, discontinuous flow centrifugal system and unwashed blood filter system. The unwashed blood filter system for autotransfusion is more popular than other systems because it is inexpensive system and easy to use. This technology had led to increased use of centrifugation devices for blood collection. During cardiopulmonary bypass (CPB) blood is collected from patient active bleeding site by the help of suckers in different ways. This blood is collected in cardiotomy reservoir and it is filtered in this reservoir. Then this blood is redirected to venous reservoir where it is oxygenated and finally it is returned to patient body.
Heart Association, globally over 80 million people suffer from heart health problems. This is occurring due to change in life style of people and consumption of high amount of fats and sugar. The complication in allogenic blood transfusion which results in significant loss of blood during cardiac surgery has led to the rise in demand for cardiopulmonary autotransfusion systems. Beside that innovation in the autotransfusion system due to advancement in technology has also boosted the global market of cardiopulmonary autotransfusion devices.
In 2019, the market size of Cardiopulmonary Autotransfusion Devices is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Cardiopulmonary Autotransfusion Devices.
This report studies the global market size of Cardiopulmonary Autotransfusion Devices, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Cardiopulmonary Autotransfusion Devices production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Fresenius Kabi
Haemonetics
LivaNova
Medtronic
Terumo
Stryker
Atrium Medical
...
Market Segment by Product Type
On-Pump Transfusion Device
Off-Pump Transfusion Device
Market Segment by Application
Hospitals
Ambulatory Surgical Center
Cardiac Research Centers
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Cardiopulmonary Autotransfusion Devices status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Cardiopulmonary Autotransfusion Devices manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Cardiopulmonary Autotransfusion Devices are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025